SU

Smita Upendra Mithani

Active Director Whole-Time Director DIN 00285350
DIN 00285350 First appointment Nov 1989 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Nov 1989
Shareholding value •••• Premium profile

About Smita Upendra Mithani

Data last updated:

Smita Upendra Mithani is a Whole-Time Director at Ankit Raj Organo Chemicals Limited (since 1989), Director at Mithani Enterprises Private Limited (since 2014) and Whole-Time Director at Mithani Finance Limited (since 2007). The companies operate in Chemicals and Materials, Financial Services and Infrastructure and Utilities. The 3 current companies with reported revenue have a combined latest revenue of ₹63.95 Cr; the largest is Ankit Raj Organo Chemicals Limited at ₹62.11 Cr (FY 2025). Earlier, Smita Upendra Mithani was a Partner at Manmantra Infracon Llp (2014–2023).

DIN 00285350
Primary Designation Whole-Time Director
Industry Chemicals and Materials
First Appointment 17 Nov 1989
Oldest Company Age 36 yrs
Largest company Ankit Raj Organo Chemicals Limited · ₹62.11 Cr (FY 2025)
Combined revenue ₹63.95 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ankit Raj Organo Chemicals Limited U24116MH1989PLC054298
Whole-Time Director17 Nov 19891989₹62.11 Cr (FY 2025)Active
Mithani Enterprises Private Limited U70102MH2014PTC252426
Director23 Jan 20142014₹1.40 Cr (FY 2024)Active
Mithani Finance Limited U65920MH1999PLC118769
Whole-Time Director10 Mar 20071999₹44 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner29 Apr 20142011Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ankit Raj Organo Chemicals Limited
Mithani Finance Limited
Mithani Enterprises Private Limited
Manmantra Infracon Llp
Premium access

Shareholding and investment profile for Smita Upendra Mithani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smita Upendra Mithani

Smita Upendra Mithani currently holds 3 directorships: Ankit Raj Organo Chemicals Limited (Whole-Time Director, since 17 Nov 1989, revenue ₹62.11 Cr (FY 2025)); Mithani Enterprises Private Limited (Director, since 23 Jan 2014, revenue ₹1.40 Cr (FY 2024)); Mithani Finance Limited (Whole-Time Director, since 10 Mar 2007, revenue ₹44 Lakh (FY 2025)).

Smita Upendra Mithani was first appointed on 17 Nov 1989 as Whole-Time Director at Ankit Raj Organo Chemicals Limited. The most recent appointment on record is 29 Apr 2014 at Manmantra Infracon Llp.

The 3 current companies of Smita Upendra Mithani that report revenue have a combined latest revenue of ₹63.95 Cr: Ankit Raj Organo Chemicals Limited ₹62.11 Cr (FY 2025); Mithani Enterprises Private Limited ₹1.40 Cr (FY 2024); Mithani Finance Limited ₹44 Lakh (FY 2025).

Smita Upendra Mithani held 1 earlier board appointment: Manmantra Infracon Llp (Partner, 29 Apr 2014 to 28 Apr 2023).

The current boards of Smita Upendra Mithani's companies include Hina Vijay Mithani (Ankit Raj Organo Chemicals Limited), Muktaben Vasantrai Mithani (Ankit Raj Organo Chemicals Limited), Upendra Vasantrai Mithani (Ankit Raj Organo Chemicals Limited), Bhumi Mithani Upendra (Mithani Enterprises Private Limited), Pooja Upendra Mithani (Mithani Finance Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available